🇨🇦 non-nucleoside reverse transcriptase inhibitors in Canada

non-nucleoside reverse transcriptase inhibitors (non-nucleoside reverse transcriptase inhibitors) regulatory status in Canada.

Marketing authorisation

non-nucleoside reverse transcriptase inhibitors in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is non-nucleoside reverse transcriptase inhibitors approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for non-nucleoside reverse transcriptase inhibitors in Canada?

French National Agency for Research on AIDS and Viral Hepatitis is the originator. The local marketing authorisation holder may differ — check the official source linked above.